FDAnews Device Daily Bulletin
Medical Devices / Submissions and Approvals

Bausch + Lomb Achieves FDA Clearance for Crystalsert Injector

Jan. 5, 2018
A A

The FDA issued 510(k) marketing clearance for the Bausch + Lomb Cystalsert 2.6 injector.

The first-of-its-kind FDA-cleared injector can be used across the company’s suite of intraocular lenses.

The CI-26 allows for easy wound entry and helps prevent tissue snagging via an incision as small as 2.6 mm, the company said.

View today's stories